FGFR2 Amplification
Clinical trial pipeline · Data from ClinicalTrials.gov
See which FGFR2 Amplification trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which FGFR2 Amplification trials you may qualify forThis is an open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), pharmacodynamic (what the drug doe…
This is a Phase 1/2, open-label, FIH study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDy), and antineoplastic acti…